Evaluation of Coronary Flow Level with Mots-C in Patients with STEMI Undergoing Primary PCI.
Tolga ÇakmakErdoğan YaşarEsin ÇakmakSuat TekinYasin KarakuşCaner TürkoğluFurkan YükselPublished in: Arquivos brasileiros de cardiologia (2023)
MOTS-C is a strong and independent predictor of no-reflow and in-hospital MACE in patients with STEMI. It was also noted that low MOTS-C levels may be an important prognostic marker of and may have a role in the pathogenesis of STEMI.
Keyphrases
- percutaneous coronary intervention
- st elevation myocardial infarction
- st segment elevation myocardial infarction
- coronary artery disease
- acute myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- coronary artery bypass grafting
- coronary artery
- healthcare
- atrial fibrillation
- coronary artery bypass
- heart failure
- acute care
- adverse drug
- emergency department
- aortic valve
- transcatheter aortic valve replacement